Piperazine

Piperazine

SCHEMBL30007068

C1CNCCN1.C=CC(=O)O.C=CC(=O)O

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.62
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TSHR P16473 4/20 0.38
HIF1A Q16665 1/20 0.38
GABRP O00591 1/20 0.38
GABRD O14764 1/20 0.38
GABRA1 P14867 1/20 0.38
GABRB1 P18505 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA5 P31644 1/20 0.38
GABRA3 P34903 1/20 0.38
GABRA2 P47869 1/20 0.38
GABRB2 P47870 1/20 0.38
GABRA4 P48169 1/20 0.38
GABRE P78334 1/20 0.38
PMP22 Q01453 1/20 0.38
GABRA6 Q16445 1/20 0.38
GABRG1 Q8N1C3 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperazine SCHEMBL28153791 1.00 LMNA (0.62) LMNAALOX15HSD17B10TSHRHIF1A
Acrylic Acid SCHEMBL9592581 0.97
Acrylic Acid SCHEMBL7996084 0.92 LMNA (0.53) LMNAALOX15HSD17B10TSHRHIF1A
Piperazine SCHEMBL28454920 0.89 LMNA (0.50) LMNAALOX15HSD17B10TSHRHIF1A
Pyrrolidine SCHEMBL29060582 0.88 LMNA (0.56) LMNAALOX15HSD17B10TSHRGABRP
Acrylic Acid SCHEMBL11118606 0.88 LMNA (0.56) LMNAALOX15HSD17B10TSHRALDH1A1
Piperidine SCHEMBL4407343 0.86 LMNA (0.53) LMNAALOX15HSD17B10TSHRGABRP
Acrylic Acid SCHEMBL672176 0.83
Acrylic Acid SCHEMBL673880 0.83
Acrylic Acid SCHEMBL28340495 0.81 LMNA (0.62) LMNAALOX15HSD17B10TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4106913-A1 COMPOSITIONS, METHODS AND SYSTEMS FOR SAMPLE PROCESSING 10X Genomics, Inc. (US) 2022-12-28 EP claimed
CN-115461143-A Compositions, methods, and systems for sample processing 10X基因组学有限公司 2022-12-09 CN claimed
EP-4499775-A1 SYSTEMS AND METHODS IN WHICH POLYACRYLAMIDE GEL IS USED TO RESIST CORROSION OF A WELLHEAD COMPONENT IN A WELL CELLAR Saudi Arabian Oil Company (SA) 2025-02-05 EP disclosed
CN-118974203-A System and method for using polyacrylamide gel to resist corrosion of wellhead components in square wells 沙特阿拉伯石油公司 2024-11-15 CN disclosed
US-11988060-B2 Systems and methods in which polyacrylamide gel is used to resist corrosion of a wellhead component in a well cellar SAUDI ARABIAN OIL COMPANY (SA) 2024-05-21 US disclosed
US-20230313628-A1 SYSTEMS AND METHODS IN WHICH POLYACRYLAMIDE GEL IS USED TO RESIST CORROSION OF A WELLHEAD COMPONENT IN A WELL CELLAR SAUDI ARABIAN OIL COMPANY (SA) 2023-10-05 US disclosed
WO-2023192577-A1 SYSTEMS AND METHODS IN WHICH POLYACRYLAMIDE GEL IS USED TO RESIST CORROSION OF A WELLHEAD COMPONENT IN A WELL CELLAR SAUDI ARABIAN OIL COMPANY (SA) 2023-10-05 WO disclosed
EP-4106913-A1 COMPOSITIONS, METHODS AND SYSTEMS FOR SAMPLE PROCESSING 10X Genomics, Inc. (US) 2022-12-28 EP disclosed
US-20220397545-A1 PHOTOCHEMICAL-BASED METHOD FOR ENZYME IMMOBILIZATION ON BIOSENSOR ELECTRODES LAXMI THERAPEUTIC DEVICES INC (US) 2022-12-15 US disclosed
CN-115461143-A Compositions, methods, and systems for sample processing 10X基因组学有限公司 2022-12-09 CN disclosed